[PRLD] QoQ Quarter Result on 31-Dec-2021 [#Q4]

Stock
[PRLD] Prelude Therapeutics Incorporated
Announcement Date
17-Mar-2022
Financial Year
2021
Quarter
31-Dec-2021 [#Q4]
Profit Trend
QoQ- -7.02%
YoY- -70.61%
Quarter Report
PRLD's Result
PRLD's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -29,958 -27,374 -29,465 -32,842 -30,687 -26,865 -21,300 25.50%
Tax -448 -2,087 -823 -168 -356 -290 -282 36.11%
NP -29,510 -25,287 -28,642 -32,842 -30,687 -26,865 -21,300 24.25%
Tax Rate - - - - - - - -
Total Cost 29,510 25,287 28,642 32,842 30,687 26,865 21,300 24.25%
Ratio Analysis
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
EPS -0.62 -0.53 -0.61 -0.71 -0.66 -0.58 -0.47 20.26%
EPS Diluted -0.62 -0.53 -0.61 -0.71 -0.66 -0.58 -0.47 20.26%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.